PharmExec Blog

Preparing for Reentry: A Physician’s Story

By Daniel Laury, M.D.

You would expect that, given a physician shortage, my goal of getting back into obstetrics would be supported and even welcomed.  The Association of American Medical Colleges expects that the US will have over 91,000 too few physicians by 2020.  I graduated medical school in 1988, completed an OBG residency in 1992 and went right into private practice.  By 2002, I stopped delivering babies, focusing on gynecology, women’s primary care, esthetics, teaching, writing and research.

It became increasingly clear that the private practice model has been disappearing over time. Our reimbursement is going down, our costs are up, we are underrepresented in negotiations, etc.  The AMA found that since 1983, physicians in private practice have decreased from 40.5% of the total to about 18.5% in 2012.  I was tired of the constant competition; in the US, the average number of OBs is one for every 13,021 persons. However, in my locale it was closer to 1 in 4,375. I was not looking forward to buying and getting trained on $50,000 of EMR.  The administrative burden of OSHA, CLIA, ACA, HIPAA and other acronyms was unsupportable.  Taking time off in private practice is also costly; income stops when I am not working but expenses continue including rent, staffing costs, malpractice premiums… Patients can be unhappy when you take time off, expecting that their private doctor is always available to them.

Mark Twain’s comment, “Twenty years from now you will be more disappointed by the things that you didn’t do than by the ones you did do” rang true for me.  I looked at my options, many that may be familiar to you, including administrative work, insurance opportunities, working for the military, writing full time, academics, giving talks and going into another field altogether. Ultimately, I decided that locums tenens work with be the best fit. I talked to various providers and overall, they seemed happier, more mobile and worked when they wanted to.   Read More »

Posted in Guest Blog, healthcare | Tagged , , | Leave a comment

Showing Patients the Bigger Mobile Health Picture

To understand just how far mobile and digital technology can truly influence progress in global healthcare, we first need to form the foundation of the discussion with a few rudimentary facts.

  1. Clinical research (“a branch of medical science in human beings”) is critical to healthcare.
  2. All patients are human beings.
  3. All stakeholders are current or potential patients.
  4. All stakeholders therefore have a vested interest in progression of healthcare.

Our current healthcare model is evolving, slowly but surely. How this progression is defined, and how mobile and digital technology can help to speed this along, is explored in this Applied Clinical Trials article by Judith Teall.

Posted in healthcare, Technology | Tagged , , | Leave a comment

Market Access in Ukraine

by Lana Sinichkina  and Leonid Cherniavskyi.

On September 16, 2014, the Ukrainian and European parliaments ratified the EU–Ukraine Association Agreement (AA), providing for harmonization of many spheres of Ukrainian legislation with EU policy.

In line with the signed AA, the government has adopted a detailed implementation plan, which endorses for preparation and approval by the end of 2015 the concept for a new healthcare system in Ukraine. The concept covers all fields of the healthcare sector, from education and self-government of healthcare professionals to financing public hospitals and reimbursement of the cost of medicinal products and medical devices to patients. Although the concept is still to be elaborated and approved, the reform legislation continues apace, with the long-term goal of establishing a developed and sustainable regulatory framework in Ukraine. Read More »

Posted in Europe, Global, Guest Blog, healthcare, Op-Ed, pricing, Regulatory | Tagged , , , | Leave a comment

NIH Invests in Biomedical Big Data

The National Institutes of Health (NIH) announced yesterday that it is issuing nearly $32 million in grants for the development of strategies to analyze and leverage biomedical data sets.  The grants are part of NIH’s Big Data to Knowledge (BD2K) initiative, launched in December 2013. BD2K is funded from all 27 NIH institutes and centers, as well as the NIH Common Fund. Read More »

Posted in healthcare, Strategy, Technology | Tagged , , | Leave a comment

AMCP Talk Pricing of Specialty Pharma Spurred by Sovaldi

Starting off this week’s Academy of Managed Care Pharmacy (AMCP) meeting in Boston, experts including patient access advocates, pharma and payer representatives came together for this year’s symposium entitled “Specialty Pharmacy and Patient Care: Are We at a Tipping Point?” Read More »

Posted in healthcare, Market Access, pricing | Tagged , , , , , , , | Leave a comment
  • Categories

  • Meta